Page 103 - Syndipharma

NanoAlvand

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Founded: 2011

No.1462, Avicenna incubation center of Tehran university of Medical Sciences,
HQ Office:
North Kargar Ave., Tehran, Iran

1. No.1462, Avicenna incubation center of Tehran university of Medical Sciences,
Plant Location: North Kargar Ave., Tehran, Iran
2. 7th west St., Simin dasht Industrial Area, Karaj,Alborz,Iran

Employees: 263

Company Profile:
The primary mission of NanoAlvand is to manufacture the latest hazardous pharmaceutical finished products in
local and international markets
• Vision: Entrance to Global markets as a trusted Manufacturer of hazardous products
• Mission: To improve quality of life and life expectancy among patients
a)Quality: Quality is the corner stone of NanoAlvand and each personnel and manager in every level is
responsible and accountable for providing the highest quality.
b)Knowledge based structure: NanoAlvand has exploited the most updated knowledge and technology to
provide the best quality by the most precise scientific methods. NanoAlvand is Employing the knowledge and
expertise of pharmaceutical, analytical chemistry and medicinal chemistry scientists to develop hazardous
pharmaceutical products with the highest quality.
c)Environmental responsibility: Using innovative neutralization Ozone based Waste treatment system, in
addition to chemical and incineration waste management systems.

Production Lines:
As Manufacturer of hazardous products, the whole production process is carried out in isolators or fully containment
systems (OEB grade 4,5). Lines are dedicated to production of Oral dosage forms and parenteral formulations.
••Parenteral Sterile Production site at Avicenna Tech. Park, Tehran, Iran
• 500 m Cleanroom
2
• Dedicated production line for sterile hazardous injectable products with isolator technology (OEB 4/5)
•• Oral dosage form production site at Simin dasht Industrial area, Karaj, Iran
• 1850 m2 Cleanrooms.
• Dedicated production line for Oral dosage form, hazardous products with full containment and isolator
technology (OEB 4/5)

Certificates:
GMP for Sterile Hazardous Injectable Products from Iranian FDA
GMP for Oral Hazardous Products from Iranian FDA
GMP Approval from Kimadia, Iraq
GMP approval form Ministry of health, Syria
GMP approval from National drug authority, Uganda

Target Countries for Exports:
Middle east, CIS, Eastern Europe
102